Metagenomi
Discovering the next generation of gene-editing systems for use in treating genetic diseases. Learn more
Launch date
Employees
Market cap
$101m
Enterprise valuation
($151m) (Public information from Sep 2024)
Share price
$2.63 MGX
Emeryville California (HQ)
Authorizing premium user...